Scarica l'app Stockscreener
3.69
7.11%
0.245
Pre-mercato:
3.51
-0.18
-4.88%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLDB Giù?
Forum
Previsione
Frazionamento azionario
Solid Biosciences Inc Borsa (SLDB) Ultime notizie
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Solid Biosciences Expands Team with 43,374 RSU Grants in Strategic Hiring Move - Stock Titan
Sarepta safety update on Elevidys boosts Regenxbio, hurts Solid Bio - MSN
Truist Financial Keeps Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail
Solid Biosciences Inc.'s (NASDAQ:SLDB) market cap dropped US$53m last week; Private equity firms bore the brunt - simplywall.st
Regenxbio stock up, Solid Bio down post Sarepta update (RGNX) - Seeking Alpha
Solid Biosciences Inc. (SLDB): Among Top Insider Purchases Last Month - Insider Monkey
Solid Biosciences director Kahn Clare buys $9,924 in stock - Investing.com India
Solid Biosciences director Kahn Clare buys $9,924 in stock By Investing.com - Investing.com Australia
Solid Biosciences’ SWOT analysis: gene therapy firm’s stock poised for growth - Investing.com Australia
Solid Biosciences’ SWOT analysis: gene therapy firm’s stock poised for growth By Investing.com - Investing.com South Africa
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Solid Biosciences Inc. (NASDAQ:SLDB) Short Interest Update - Defense World
Q1 EPS Forecast for Solid Biosciences Boosted by Analyst - Defense World
Top 10 Insider Purchases Last Month - Insider Monkey
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - GlobeNewswire
Solid Biosciences Inc. to Present Phase 1/2 INSPIRE DUCHENNE Trial Data on SGT-003 Gene Therapy for Duchenne Muscular Dystrophy at 2025 MDA Conference - Nasdaq
Breakthrough DMD Gene Therapy Results: Solid Bio Reveals INSPIRE Trial Data at Major Conference - StockTitan
Solid Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Solid Biosciences Inc. (NASDAQ:SLDB) Shares Acquired by Rhumbline Advisers - Defense World
HC Wainwright Issues Positive Forecast for Solid Biosciences (NASDAQ:SLDB) Stock Price - Defense World
Solid Biosciences shares leap on raised price target to $20 By Investing.com - Investing.com Canada
Solid Biosciences price target raised to $20 from $16 at H.C. Wainwright - TipRanks
FY2026 Earnings Forecast for SLDB Issued By William Blair - Defense World
Chardan Capital Reaffirms “Buy” Rating for Solid Biosciences (NASDAQ:SLDB) - Defense World
SLDB Stock Rallies 60% in a Month: Here's What You Should Know - MSN
Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade - Yahoo Finance
Solid Biosciences Inc expected to post a loss of 60 cents a shareEarnings Preview - TradingView
Solid Biosciences stock target holds at $15 on therapy optimism - Investing.com
Solid Biosciences: Promising Gene Therapy Advancements and Strategic Pipeline Expansion Justify Buy Rating - TipRanks
Solid Biosciences: Positive DMD Program Developments and Strong Financial Position Justify Buy Rating - TipRanks
Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire
Solid Biosciences Inc. (SLDB) reports earnings - Quartz
Solid Biosciences reports Q4 EPS ($1.00), consensus (78c) - TipRanks
Solid Biosciences Reports Positive Data from Duchenne Gene Therapy Trial and Provides Business Update - Nasdaq
Solid Biosciences Inc. SEC 10-K Report - TradingView
SLDBSolid Bioscience Latest Stock News & Market Updates - Stock Titan
Duchenne Patient Stories - Solid Biosciences
Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewswire
Genetic Medicine Developer Solid Biosciences Sets March Conference Schedule: What's Coming? - StockTitan
Solid Biosciences (SLDB) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Is Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
How Solid Biosciences Uses Equity Compensation to Attract New Talent - StockTitan
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
3 Reasons to Sell CSL and 1 Stock to Buy Instead - The Globe and Mail
Solid Biosciences Inc. (SLDB) Latest Stock News & Headlines - Yahoo Canada Finance
Leerink Partnrs Issues Optimistic Outlook for SLDB Earnings - MarketBeat
2.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):